On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales of $22.47 ...
At its CIIE booth, the company also announced the China market launch of TECVAYLI®, an injection to treat relapsed or refractory multiple myeloma, which has the second highest incidence rate among all ...
It has been nearly a year since my last Johnson & Johnson (NYSE ... The company’s neuroscience products are also contributing with SPRAVATO recording 55.3% growth. J&J’s OPSUMIT and UPTRAVI ...
Jennifer Lawrence will be voting for Kamala Harris in the 2024 presidential election. “I think she’s an amazing candidate and I know that she will do whatever she can to protect reproductive rights,” ...